340B Manufacturer Fines Outlined In Rule, But HRSA Expects To Use Them ‘Very Rarely’
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed rule would implement how civil monetary penalties will be applied to manufacturers that “knowingly and intentionally” deny 340B prices to eligible health care providers.